Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China · Delayed Price · Currency is CNY 10.06
+0.32 (3.29%)
Sep 30, 2026, 3:04 PM CST
SHE:000403 Market Cap
SHE:000403 has a market cap or net worth of 9.44 billion as of October 2, 2026. Its market cap has decreased by -38.52% in one year.
Market Cap
9.44B
Enterprise Value
9.56B
Revenue
2.48B
Ranking
n/a
PE Ratio
35.68
Stock Price
10.06
ChartMarket Cap Chart
Since September 23, 1996, SHE:000403's market cap has increased from 230.36M to 9.44B, an increase of 3,996.17%. That is a compound annual growth rate of 13.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.44B | -27.48% |
| Dec 31, 2025 | 13.01B | -15.77% |
| Dec 31, 2024 | 15.45B | -22.60% |
| Dec 29, 2023 | 19.96B | 19.73% |
| Dec 30, 2022 | 16.67B | -18.85% |
| Dec 31, 2021 | 20.54B | 9.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 10.55B |
| Chengzhi | 10.50B |
| Staidson (Beijing) BioPharmaceuticals | 9.77B |
| Jiangxi Fushine Pharmaceutical | 9.62B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.41B |
| Chongqing Genrix Biopharmaceutical | 9.28B |
| Chengdu Easton Biopharmaceuticals | 8.88B |
| Vcanbio Cell & Gene Engineering Corp., | 8.85B |